Mass firings at the FDA have decimated divisions tasked with releasing public records generated by the agency's regulatory ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER ...

As the Trump administration cuts thousands of federal jobs, some fired workers worry about health agencies' ability to ...

The Food and Drug Administration is reversing course on its requirement for all staffers to report to the office ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request ...

Marks is highly regarded by former FDA leaders and biotech industry executives, but his time at the agency has not been ...

Novavax started the week hoping the FDA would issue a full approval of its Covid vaccine. But the decision never came.

Kennedy Jr., and that the deputy commissioner at the FDA intervened in the Novavax decision ... was a pause on the review of ...

FRIDAY, April 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has delayed the full approval of Novavax’s COVID-19 vaccine. The decision had been expected by April 1, but the ...

A person familiar with the situation told CNN that the FDA is seeking more data on the vaccine, which has been available under emergency use authorization since 2022. It was the first Covid-19 ...